Dermata Therapeutics, Inc. General form of registration statement for all companies including face-amount certificate companies

Balance Sheet Details (Tables)

12 Months Ended

Dec. 31, 2021

	As of December 31,
	2021		2020

Prepaid expenses and other current assets
Prepaid insurance	$	769,416	$	68,003
Prepaid research and development costs		-		7,050
Deferred offering costs		55,718		-
Total prepaid expenses and other current assets	$	825,134	$	75,053

Accrued and other current liabilities
Accrued interest payable	$	-	$	49,169
Accrued research and development costs		235,384		-
Accrued compensation and benefits		766,207		84,308
Total accrued and other current liabilities	$	1,001,591	$	133,477